Raymond James & Associates’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $7.2M | Buy |
62,446
+2,552
| +4% | +$350K | ﹤0.01% | 1414 |
|
|
2024
Q2 | $8.25M | Sell |
59,894
-454
| -0.8% | -$62.3K | 0.01% | 1274 |
|
|
2024
Q1 | $8.32M | Buy |
60,348
+2,275
| +4% | +$311K | 0.01% | 1265 |
|
|
2023
Q4 | $7.65M | Sell |
58,073
-524
| -0.9% | -$60.3K | 0.01% | 1273 |
|
|
2023
Q3 | $6.59M | Sell |
58,597
-939
| -2% | -$98.9K | 0.01% | 1286 |
|
|
2023
Q2 | $5.61M | Sell |
59,536
-18,758
| -24% | -$1.83M | ﹤0.01% | 1400 |
|
|
2023
Q1 | $7.92M | Buy |
78,294
+358
| +0.5% | +$37.3K | 0.01% | 1172 |
|
|
2022
Q4 | $9.31M | Buy |
77,936
+5,744
| +8% | +$673K | 0.01% | 1032 |
|
|
2022
Q3 | $7.67M | Buy |
72,192
+7,676
| +12% | +$779K | 0.01% | 1109 |
|
|
2022
Q2 | $6.29M | Sell |
64,516
-15,230
| -19% | -$1.41M | 0.01% | 1251 |
|
|
2022
Q1 | $7.48M | Buy |
79,746
+14,089
| +21% | +$1.19M | 0.01% | 1235 |
|
|
2021
Q4 | $5.59M | Sell |
65,657
-87,675
| -57% | -$8.07M | ﹤0.01% | 1477 |
|
|
2021
Q3 | $14.7M | Sell |
153,332
-9,022
| -6% | -$852K | 0.01% | 860 |
|
|
2021
Q2 | $15.8M | Sell |
162,354
-19,009
| -10% | -$1.82M | 0.01% | 829 |
|
|
2021
Q1 | $17.6M | Sell |
181,363
-8,652
| -5% | -$907K | 0.02% | 723 |
|
|
2020
Q4 | $18.2M | Buy |
190,015
+78,516
| +70% | +$7.58M | 0.02% | 662 |
|
|
2020
Q3 | $10.7M | Buy |
111,499
+3,178
| +3% | +$368K | 0.01% | 823 |
|
|
2020
Q2 | $13.2M | Buy |
108,321
+10,860
| +11% | +$1.2M | 0.02% | 689 |
|
|
2020
Q1 | $8.44M | Buy |
97,461
+3,621
| +4% | +$354K | 0.01% | 813 |
|
|
2019
Q4 | $10.1M | Buy |
93,840
+3,842
| +4% | +$402K | 0.01% | 894 |
|
|
2019
Q3 | $8.11M | Buy |
89,998
+14,973
| +20% | +$1.4M | 0.01% | 963 |
|
|
2019
Q2 | $6.33M | Buy |
75,025
+17,853
| +31% | +$1.47M | 0.01% | 1094 |
|
|
2019
Q1 | $5.04M | Buy |
57,172
+27,732
| +94% | +$2.32M | 0.01% | 1183 |
|
|
2018
Q4 | $2.1M | Sell |
29,440
-8,819
| -23% | -$845K | ﹤0.01% | 1630 |
|
|
2018
Q3 | $4.7M | Buy |
38,259
+27,866
| +268% | +$3.16M | 0.01% | 1248 |
|
|
2018
Q2 | $1.02M | Buy |
10,393
+1,109
| +12% | +$99.3K | ﹤0.01% | 2198 |
|
|
2018
Q1 | $770K | Buy |
9,284
+158
| +2% | +$13.3K | ﹤0.01% | 2301 |
|
|
2017
Q4 | $708K | Sell |
9,126
-13,550
| -60% | -$924K | ﹤0.01% | 2330 |
|
|
2017
Q3 | $1.39M | Buy |
22,676
+15,346
| +209% | +$810K | ﹤0.01% | 1890 |
|
|
2017
Q2 | $337K | Sell |
7,330
-1,500
| -17% | -$72.8K | ﹤0.01% | 2651 |
|
|
2017
Q1 | $382K | Sell |
8,830
-4,818
| -35% | -$206K | ﹤0.01% | 2548 |
|
|
2016
Q4 | $528K | Sell |
13,648
-5,881
| -30% | -$266K | ﹤0.01% | 2307 |
|
|
2016
Q3 | $989K | Buy |
19,529
+10,536
| +117% | +$525K | ﹤0.01% | 1890 |
|
|
2016
Q2 | $409K | Sell |
8,993
-162
| -2% | -$7.46K | ﹤0.01% | 2217 |
|
|
2016
Q1 | $362K | Sell |
9,155
-1,328
| -13% | -$52.7K | ﹤0.01% | 2223 |
|
|
2015
Q4 | $593K | Buy |
+10,483
| New | +$533K | ﹤0.01% | 1897 |
|
Other funds holding NBIX
BG
